Press release

3 March, 2022

Erratum to the Press Release "Kringle Pharma Appoints Hideyuki Okano, M.D., Ph.D.

as Scientific Advisor" dated March 1, 2022

An editorial error was made in the press release dated March 1, 2022 (English version only) announcing the appointment of Hideyuki Okano, M.D., Ph.D., Professor, Department of Physiology, Keio University School of Medicine, as a scientific advisor. The error was occurred in one line of the biography of Dr. Okano, being corrected as follows:

Correct:

2017 Dean, Keio University Graduate School of Medicine (to 2021)

Incorrect:

2017 Chairman Keio University Graduate School of Medicine Research Division (to 2021)

All the other descriptions are correct and remain unchanged.

For more information, please contact：

Daichika Hayata

Director, Pharmaceutical Development

Kringle Pharma, Inc.

  • +81-72-641-8739
  • kpinfo@kringle-pharma.com

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Kringle Pharma Inc. published this content on 03 March 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 March 2022 08:59:06 UTC.